Trial Profile
Osteoporotic treatment with eldecalcitol in patients with rheumatic disease.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 May 2015
Price :
$35
*
At a glance
- Drugs Eldecalcitol (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 27 May 2015 New trial record
- 29 Mar 2015 Results presented at the 2015 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.